within Pharmacolibrary.Drugs.ATC.G;

model G03XC04
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 8.333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 30 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.12,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.002,
    Tlag           = 900,            
    Vdp             = 0.3,
    k12             = 3,
    k21             = 3
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03XC04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ormeloxifene is a selective estrogen receptor modulator (SERM) used primarily as a non-steroidal, weekly oral contraceptive in India. It has also been studied for potential applications in dysfunctional uterine bleeding and certain hormone-sensitive cancers. While approved and marketed in India, it is not approved for use in most other countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported in healthy adult women following the standard oral contraceptive dose regimen.</p><h4>References</h4><ol><li><p>Kabra, R, et al., &amp; Kiarie, J (2019). Scoping review to map evidence on mechanism of action, pharmacokinetics, effectiveness and side effects of centchroman as a contraceptive pill. <i>BMJ open</i> 9(10) e030373–None. DOI:<a href=\"https://doi.org/10.1136/bmjopen-2019-030373\">10.1136/bmjopen-2019-030373</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31594884/\">https://pubmed.ncbi.nlm.nih.gov/31594884</a></p></li><li><p>Lal, J (2010). Clinical pharmacokinetics and interaction of centchroman--a mini review. <i>Contraception</i> 81(4) 275–280. DOI:<a href=\"https://doi.org/10.1016/j.contraception.2009.11.007\">10.1016/j.contraception.2009.11.007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20227542/\">https://pubmed.ncbi.nlm.nih.gov/20227542</a></p></li><li><p>Lal, J, et al., &amp; Gupta, RC (1995). Pharmacokinetics of centchroman in healthy female subjects after oral administration. <i>Contraception</i> 52(5) 297–300. DOI:<a href=\"https://doi.org/10.1016/0010-7824(95)00213-t\">10.1016/0010-7824(95)00213-t</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8585886/\">https://pubmed.ncbi.nlm.nih.gov/8585886</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03XC04;
